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Most estimates of the cost of informal caregiving in patients
with Alzheimer’s disease (AD) remain cross-sectional. Lon-
gitudinal estimates of informal caregiving hours and costs
are less frequent and are from assessments covering only
short periods of time. The objectives of this study were to
estimate long-term trajectories of the use and cost of infor-
mal caregiving for patients with AD and the effects of pa-
tient characteristics on the use and cost of informal
caregiving. The sample is drawn from the Predictors Study,
a large, multicenter cohort of patients with probable AD,
prospectively followed annually for up to 7 years in three
university-based AD centers in the United States (n5170).
Generalized linear mixed models were used to estimate the
effects of patient characteristics on use and cost of informal
caregiving. Patients’ clinical characteristics included cogni-
tive status (Mini-Mental State Examination), functional
capacity (Blessed Dementia Rating Scale (BDRS)), comor-
bidities, psychotic symptoms, behavioral problems, depres-
sive symptoms, and extrapyramidal signs. Results show
that rates of informal care use and caregiving hours (and
costs) increased substantially over time but were related
differently to patients’ characteristics. Use of informal care
was significantly associated with worse cognition, worse
function, and higher comorbidities. Conditional on receiv-
ing informal care, informal caregiving hours (and costs)
were mainly associated with worse function. Each addi-
tional point on the BDRS increased informal caregiving
costs 5.4%. Average annual informal cost was estimated at
$25,381 per patient, increasing from $20,589 at baseline to
$43,030 in Year 4. J Am Geriatr Soc 54:1596–1602, 2006.
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Informal caregivers provide the majority of care for pa-tients with Alzheimer’s disease (AD) living in the com-
munity. As patients with AD become progressively less
capable of self-care over time and rely on others to manage
and supervise the most basic mental and physical tasks,
informal care becomes increasingly more time consuming.
Eventually, patients with AD reach a level of disability that
requires constant care and supervision. Existing estimates
of informal caregiving hours that patients receive range
from 13 to 107 hours per week, with associated costs of
between $2,019 and $19,688 per year.1 Most of these stud-
ies are cross-sectional. Longitudinal estimates of informal
caregiving hours and cost are less frequent and are from
assessments covering only short time periods.2,3
In the Predictors Study, a large, multicenter cohort of
patients with probable AD was followed from early stages
of the disease in three university-based AD centers in the
United States. The goals of this study are to estimate em-
pirically long-term trajectories of informal caregiving hours
and costs of AD and relate them to patient characteristics.
The longitudinal design offers several advantages. The most
important one is that patients were recruited at early stages
of the disease and followed for long periods of time so that
the cohort encompasses the full range of disease progres-
sion. Longer-term effects on informal caregiving hours and
costs are therefore more easily interpreted. By estimating
informal caregiving hours and cost trajectories, it is hoped
that useful data can be provided for future evaluations of
the effects of AD on informal care.
METHODS
Sample
The sample was drawn from the Predictors 2 cohort, and
consisted of 204 patients with probable AD recruited
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between 1998 and 2004 from Columbia University Medical
Center, Johns Hopkins School of Medicine, and Massachu-
setts General Hospital. Each local institutional review
board approved the study. The inclusion and exclusion cri-
teria are fully described elsewhere.4–6 Briefly, subjects met
Diagnostic and Statistical Manual of Mental Disorders,
Third Edition, Revised, criteria for primary degenerative
dementia of the Alzheimer type and National Institute for
Neurological Disorders and Stroke/Alzheimer’s Disease and
Related Disorder Association criteria for probable AD. En-
rollment required a modified Mini-Mental State Examina-
tion score of 30 or higher, equivalent to a score of
approximately of 16 or higher on the Folstein Mini-Men-
tal State Examination (MMSE).7,8 Because subjects were
followed at academic AD centers, there is a high degree of
certainty in their AD diagnosis. Clinical diagnosis of AD
has been confirmed in 93% of those with postmortem eval-
uation.6
Recruitment of patients began in 1998. Baseline data
were collected for 13.3% of patients in 1998, 8.3% in
1999, 24.3% in 2000, 26.0% in 2001, 15.5% in 2002,
11.1% in 2003, and 1.1% in 2004. After the baseline visit,
all patients were followed semiannually, with annual as-
sessments of informal care use. At the time of data analysis,
82.4% had at least one follow-up assessment.
Because patterns of informal care utilization differ
substantially for patients living in the community and those
living in institutions,9,10 information on patients’ living ar-
rangements was collected at each visit. Of the 204 patients
in the sample, 48 (23.5%) reported living in an institutional
setting (nursing homes, assisted living facilities, retirement
homes) at some point during the study. Another 20 patients
entered the study living at home and moved to an institu-
tional setting at a later time. Four patients reported chang-
ing living environments more than once during the study.
Visits during which the patient was living in an institutional
setting were excluded from the analysis sample. Seven pa-
tients with missing information on informal care were also
excluded. For the present study, the analysis sample con-
sisted of 409 observations from 170 patients who lived at
home. Of these 170 patients, 42 had one assessment only (at
baseline), 56 had two assessments (baseline and 1 follow-up
visit), 37 had three, 23 had four, 10 had five, and two had
six assessments. Median follow-up for the cohort was 2.5
years; maximum was 6 years. Patients who did not respond
at a particular visit could respond at a subsequent visit.
Measures
Informal Caregiving Time and Cost
Informal caregiving time was asked for up to three care-
givers on basic and instrumental activities of daily living.
Basic activities of daily living included eating, dressing, and
personal care. Instrumental activities of daily living includ-
ed shopping, chores, personal business, and transportation.
Hours of informal care provided per day for each caregiving
task were asked in the following categories: 0, o3, 3 to 6,
46 to 9, 49 to 12, & 412. The mean value of each cat-
egory was used to estimate caregiving hours (412 was top
coded to 12). Hours provided for each task were summed to
obtain an estimate of the total caregiving hours. Following
the literature, total caregiving hours were top coded at 16
hours.11 Top coding affected six (1%) observations. The
national average hourly earning for all private industries for
each year was used as the hourly wage rate to estimate
unpaid caregiving costs.12 Because 12.0% to 23.5% of the
patients did not receive any informal care at each visit, a
dichotomous variable was constructed to measure informal
care utilization.
Clinical and Demographic Characteristics
Disease progression was characterized using MMSE score.7
Higher MMSE scores indicate better cognitive status. For
ease of presenting descriptive results, MMSE scores were
categorized into two groups at a cutpoint of 20, because it
marked a transition from mild (MMSE 420) to moderate
dementia (MMSE 20). Blessed Dementia Rating Scale
(BDRS) Parts I and II were used to assess patients’ func-
tional capacity.13 Higher BDRS scores indicate worse func-
tional status. For ease of presenting descriptive results, the
BDRS scores were categorized into high- and low-func-
tioning groups at the baseline median score, because there
are no established cutoff points for this scale.
The Columbia University Scale for Psychopathology in
Alzheimer’s Disease was used to measure the presence or
absence of psychotic, behavioral, and depressive symp-
toms.14,15 Following previous work,16,17 the presence of
delusions, hallucinations, or illusions was considered to in-
dicate the presence of psychotic symptoms. The presence of
any of the following five symptoms (wandering away from
home or caregiver, verbal outbursts, physical threats or vi-
olence, agitation or restlessness, or sundowning (more con-
fusion at night or evening than during the day)) was
considered to indicate the presence of behavioral problems.
Depressed mood (feeling sad, depressed, blue) and difficulty
sleeping or a change in appetite were considered to indicate
the presence of depressive symptoms.
A modified Unified Parkinson’s Disease Rating Scale
was used to measure the presence or absence of extrapy-
ramidal signs (EPS).15,18,19 Following previous work,6,20 a
dichotomous indicator was constructed for the presence of
EPS if any of the following 11 items was rated 2 or higher (0
being normal and 4 indicating maximum impairment):
speech, facial expression, tremor at rest, neck rigidity, right
arm rigidity, left arm rigidity, right leg rigidity, left leg ri-
gidity, posture, gait, and bradykinesia.
Patients’ medical histories were used to construct a
modified version of the Charlson index of comorbidi-
ties.17,20,21 Comorbidities included myocardial infarction,
congestive heart failure, peripheral vascular disease, hyper-
tension, chronic obstructive pulmonary disease, arthritis,
gastrointestinal diseases, liver disease, diabetes mellitus,
chronic renal disease, and systemic malignancy. Patients’
age, ethnicity, sex, and highest level of education were re-
corded at the baseline visit, and marital status was recorded
at each visit.
Analysis
Informal care utilization and hours were compared using
the following clinical characteristics: functional status (high
or low); cognition (mild or moderate); comorbidities (0, 1,
2); and the presence or absences of psychotic, EPS, de-
pressive, and behavioral problems. Group comparisons of
categorical variables (utilization) were performed using
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chi-square tests, and comparisons of continuous variables
(hours) were performed using nonparametric Wilcoxon
rank sum tests.
Generalized linear mixed models were used to estimate
utilization and hours of informal care.22,23 The first part of
the model estimates the probability of receiving any infor-
mal care. The second part estimates the continuous amount
of informal care received, conditional on receiving any. Be-
cause hours of informal care were highly skewed to the right
(skewness51.91), log hours were examined as the depen-
dent variable.
Within- and between-person change in the trajectories
of informal care utilization and hours over time were es-
timated as follows. A simple model that included an inter-
cept and time as fixed effects and a random intercept term
was first estimated. Time was measured in years from base-
line (time 0). Time (year) squared was then included in the
estimation model. The coefficient on time squared was
statistically insignificant and was dropped in subsequent
models. Potential nonlinearity was also tested for using
squared-root and cubic terms. Next a random slope was
included to allow for differences between patients in their
overall rate of increase. Likelihood ratio tests suggested that
including a random slope did not improve the model, and it
was dropped in subsequent models. Finally, patient char-
acteristics were included as fixed effects to control for any
systematic differences in the sample on these variables. All
clinical variables were entered as time-variant covariates,
and all demographic variables except marital status were
entered as time-invariant covariates.
For the first part of the model, informal care utilization,
odds ratios are reported for ease of interpreting the results.
For the second part of the model, because the dependent
variable was log-transformed, interpretation of the coeffi-
cient estimates requires some care. For continuous explan-
atory variables, a coefficient of b estimates the proportional
change in caregiving hours for a unit change in the explan-
atory variable, holding all other variables constant. That is,
a unit increase in the explanatory variable increases care-
giving hours by 100 b percent. For dichotomous explana-
tory variables, the corresponding proportional change on
caregiving hours of the explanatory variable from the ref-
erence group is estimated as 100(e(b–1/2V(b)) 1).24 All anal-
yses were performed using Stata 9.0 (StataCorp., College
Station, TX).
RESULTS
Sociodemographic and Clinical Characteristics
Because the sample used for the present analyses included
only patients living in the community, patients’ baseline
characteristics were first compared according to living ar-
rangement: lived at home throughout the study period,
lived in an institutional setting throughout the study period,
and changed living arrangement during the study. Patients
who lived in an institutional setting throughout the study
period were older (85.3 vs 75.2, Po.001), more likely to be
female (79.2% vs 56.3%, P5.03), and less likely to be
married (12.5% vs 66.7%, Po.001) than patients living in
other settings. Patients who lived in nursing homes through-
out the study period had lower MMSE scores (20.3 vs 22.1,
P5.04), higher BDRS scored (4.5 vs 3.5, P5.04), and
marginally more comorbidities (1.3 vs 0.7, P5.08). Pa-
tients who lived in nursing homes throughout the study
period were less likely to receive informal care (56.3% vs
77.5%, P5.05) and, of those who received care, received
fewer caregiving hours (12.9 vs 14.0 h/wk, P5.01). Dif-
ferences between patients who lived in retirement homes
and assisted living facilities throughout the study period
were not statistically significant, possibly because the
number of patients living in these environments was small.
Longitudinal patterns of patient characteristics are
shown in Table 1. The average patient in the sample was
aged 74.9. Half were women (50.1%). Patients in the sam-
ple were largely non-Hispanic white (95.8%), well educat-
ed (average 14.7 years of schooling), and married (71.4%)
or widowed (22.0%). Because of the study inclusion crite-
ria, all patients were initially at the early stages of AD. As
expected, patients’ cognition and function declined over
time. Number of comorbidities (mean 0.7) remained stable
over time.
Unadjusted Utilization and Caregiving Hours Received
Figure 1 presents data on informal care utilization rates
over time and, of those who received care, average care-
giving hours received per week. Usage of informal care in-
creased slightly from 76.5% at baseline to 88.0% in Year 4
(average utilization rate across years 80.7%). Of patients
receiving care, average hours received was 33.1 per week
(4.7 per day). Over time, average hours received per week
increased from 27.9 at baseline to 53.0 in Year 4. Per user
average annual cost of informal care was estimated at
$25,381, increasing from $20,589 at baseline to $43,030 in
Year 4.
Table 2 presents data on informal care utilization rates
and average weekly caregiving hours received over time
according to patients’ clinical characteristics. Except for
depressive symptoms, patients with worse clinical charac-
teristics were more likely to receive informal care. Differ-
ences in utilization rates according to clinical characteristics
were almost always consistent in each year and were sig-
nificant according to BDRS score, MMSE score, and
number of comorbidities (all Po.001). Of those who re-
ceived care, differences in hours of informal care received
were significantly different according to presence or ab-
sence of psychotic symptoms, EPS, depressive symptoms,
BDRS score, and MMSE score (all Po.05).
Adjusted Usage and Weekly Caregiving Hours
The first two columns of Table 3 present regression results
of the effects of patients’ clinical and sociodemographic
characteristics on informal care utilization. Results show
that, controlling for other covariates, utilization of informal
care remained stable over time. Each additional point in
MMSE score decreased the probability of receiving infor-
mal care 9%. Each additional point in BDRS score in-
creased the probability of receiving informal care 29.5%.
Each additional comorbidity increased the probability of
receiving informal care 62.2%. Table 3 also presents esti-
mation results of the effects of each variable on informal
caregiving hours for patients who received care. For pa-
tients who received some informal care, average informal
caregiving hours increased 9.9% per year, and each addi-
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tional point in BDRS score increased informal caregiving
hours 5.4%. Differences in hours of informal care accord-
ing to the presence of psychotic symptoms, EPS, or depres-
sive symptoms found in bivariate analyses were no longer
statistically significant.
DISCUSSION
These results extend the literature on informal caregiving
for patients with AD in a number of ways. Most existing
studies on informal caregiving costs for patients with AD
are cross-sectional and include patients at various stages
of the disease.1 This study prospectively followed a large
cohort of patients from the early stages of the disease and
examined patterns of informal caregiving utilization and
costs longitudinally. It was estimated that, on average, 80%
of AD patients living in the community received some in-
formal care. Those receiving care received an average of
33.1 hours of care per week, with an estimated cost of
$25,381 per patient per year. The consistency of the results
with existing studies indicates the validity of the data col-
lection process and costing methods used in the Predictors
Study.
Little can be said in cross-sectional studies about in-
formal caregiving trajectories. Results from a longitudinal
study show that rates of informal care utilization and care-
giving hours (and costs) increased substantially at each
subsequent follow-up. Informal cost of AD was estimated
at $20,589 per patient per year at baseline (27.9 h/wk),


































Figure 1. Utilization and hours of informal care received over
time.






























All patients 80.7 76.5 83.3 84.5 80.5 88.0 33.1 27.9 31.3 32.8 44.2 53.0
Psychotic symptoms
Not present 78.9 76.1 79.1 86.7 71.4 87.5 30.0 25.8 27.7 31.0 46.2 45.0
Present 83.9 77.4 91.4 80.8 90.0 88.9 38.5 32.3 41.0 32.0 42.6 66.9
Extrapyramidal signs
Not present 79.3 76.0 80.5 84.7 74.2 90.0 31.1 27.2 27.8 31.3 47.0 46.7
Present 87.3 79.2 95.0 83.3 100.0 80.0 41.3 31.5 49.7 31.5 37.8 81.4
Depressive symptoms
Not present 82.4 78.1 84.2 89.8 81.1 85.0 31.8 26.7 30.0 31.7 46.9 44.5
Present 73.8 69.7 80.8 58.3 75.0 100.0 38.8 33.3 41.0 28.5 17.5 81.9
Behavioral problems
Not present 77.3 72.4 80.8 81.5 84.2 81.8 30.5 25.4 29.5 32.0 40.7 53.7
Present 84.2 81.9 86.0 86.4 77.3 92.9 35.5 30.8 36.0 30.9 47.6 52.5
Blessed Dementia Rating Scale
Higher function 73.5w 70.8 75.5 82.4 75.0 33.3 27.8w 24.5 27.0 30.3 46.4 52.5
Lower function 89.6 90.0 91.8 86.5 84.0 95.5 38.4 34.3 37.9 32.2 43.0 53.0
Mini-Mental State Examination score
420 74.0w 73.5 78.8 72.7 70.6 50.0 28.3w 27.3 27.7 21.9 49.0 31.5
20 89.0 83.9 91.3 94.1 83.3 100.0 36.6 28.8 36.9 36.4 46.2 58.8
Number of comorbidities
0 72.5w 65.1 74.5 80.0 73.9 91.7 34.5 28.2 33.4 29.9 47.6 60.1
1 89.5 86.4 94.3 91.3 80.0 100.0 30.7 27.4 30.5 31.0 39.4 47.3
2 87.5 89.3 87.5 84.6 100.0 71.4 34.2 28.1 36.3 35.3 42.0 44.1
Differences by clinical characteristics significant at 5% and w1% levels.
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$43,030 in Year 4 (53.0 h/wk). These results are consistent
with two studies that reported an average increase of 7
hours per week in informal caregiving time over a year.2,3
The multivariate analyses suggest that longitudinal tra-
jectories of informal care utilization and intensity relate
differently to patients’ clinical characteristics. Patients with
worse cognition, lower function, and more comorbidities
were significantly more likely to receive informal care. Al-
ternatively, in patients who received care, informal care-
giving hours (and cost) were significantly associated only
with patients’ function. It is estimated that, with a baseline
informal caregiving cost at $20,589 per patient per year,
each additional point in BDRS score increased informal cost
by $1,112 a year.
The effects of psychotic and behavioral problems and
EPS on the cost of caring for patients with AD are not well
understood. Similar to the baseline study25 but contrary to
several cross-sectional studies that examined the effects of
behavioral problems26–28 and EPS29 on costs, the presence
of psychotic symptoms, behavior problems, or EPS were
not found to be significantly associated with higher infor-
mal caregiving costs. Differences in the results may be due
to several factors. First, informal caregiving hours reported
in this study are total hours spent caring for patients with
AD and not incremental caregiving hours, as used in pre-
vious studies. Second, the nonsignificant result found could
be partly due to the roughness of the measures used in this
study. For example, subcategories of EPS and psychotic
symptoms were grouped together, and only dichotomous
gradations of severity were used. In addition, behavioral
and psychiatric symptoms in AD fluctuate over time, and
particular symptoms can occur any time during the course
of AD.17 Persistence of these symptoms also differs from
symptom to symptom.30 The effects on hours of finer gra-
dations of subtype and severity of each symptom will be
examined in detail in future studies.
The decreasing number of patients included in the anal-
ysis over time reflects the staggered nature of the sample
recruitment and patient deaths (7%). During the period in
which each subject was followed, missed visits were rare;
15.6% missed one, 2.5% missed two, and 1% missed three
visits. Baseline characteristics of the patients who had com-
plete 4-year follow-up data were compared with those of
patients who did not. There were no differences in sociode-
mographic and clinical characteristics between the two
groups except that the completers were marginally more
likely to be married at baseline (P5.07). Utilization and cost
trajectories were also examined for the patients who had
complete 4-year follow-up data. Utilization and cost trajec-
tories for this subsample were similar to those of the entire
sample, suggesting that the cost increases that were reported
were not specific to those with long-term follow-up.
There are several limitations to this study. Patients were
selected from tertiary care university hospitals and special-
ized diagnostic and treatment centers and thus represent a
nonrandom sample of those affected by AD in the popu-
lation. Patients in the sample also were predominantly
white and highly educated. Caution is needed in general-
izing the results of this study to patients of other ethnicities
and lower levels of education and income and to patients
with AD living in the community. The relative homogeneity
of the sample may mask differences in clinical measures and
patterns of informal caregiving. For example, black and
Latino patients with moderate to severe dementia have been
Table 3. Random Effect Model of Utilization and Costs of Informal Caregiving
Variable
Utilization Rates per Patient
(n5 170)
Average Hours
per Week per User
(n5 152)
Coefficient
(Standard Error) Odds Ratio
Coefficient
(Standard Error)
Year 0.148 (0.150) 0.862 0.099 (0.037)w
Mini-Mental State Examination score 0.094 (0.047) 0.910 0.011 (0.009)
Blessed Dementia Rating Scale score 0.295 (0.106)w 1.343 0.054 (0.020)w
Number of comorbidities 0.622 (0.253) 1.862 0.017 (0.047)
Behavioral problems (15 present, 05 absent) 0.044 (0.392) 0.957 0.017 (0.090)
Extrapyramidal signs (15 present, 05 absent) 0.101 (0.531) 0.904 0.045 (0.113)
Depressive symptoms (15 present, 05 absent) 0.539 (0.444) 0.584 0.160 (0.109)
Psychotic symptoms (15 present, 05 absent) 0.760 (0.439) 0.467 0.128 (0.093)
Women (15 yes, 05 no) 0.369 (0.438) 0.691 0.056 (0.094)
Aged o65 (15 yes, 05 no) 0.466 (0.647) 1.594 0.102 (0.128)
Marital status (reference5 other)
Married (15 yes, 05 0) 1.316 (0.768) 3.728 0.212 (0.197)
Widowed (15 yes, 05 0) 0.941 (0.710) 2.563 0.078 (0.190)
Site (reference5Columbia)
Johns Hopkins 1.957 (1.794) 7.078 0.300 (0.209)
Massachusetts General Hospital 0.171 (0.431) 0.843 0.466 (0.300)
Constant 1.847 (1.450) 9.894 (0.326)w
Total number of observations 409 306
Log likelihood –158.5 –315.6
Po  .05, w .01.
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shown to have higher prevalence of dementia-related be-
havioral problem than whites.31 Sociodemographic and
cultural differences between different racial/ethnic groups
also may influence patterns of informal care and modify the
effects of the clinical variables. Although no effects on in-
formal caregiving of several important clinical variables
(e.g., depression, behavioral problems, EPS) were found in
this sample, these characteristics may be more pronounced
in more-diverse samples. Because informal caregiving pat-
terns may be different for individuals living in different en-
vironments, only patients living in the community were
included. Future research will need to examine AD cost
trajectories in samples that are more representative of the
general population.
In general, several factors support confidence in these
findings. A major contribution lies in the careful diagnosis
and clinical follow-up that patients received. Clinical diag-
nosis took place in university hospitals with specific exper-
tise in dementia and was based on uniform application of
widely accepted criteria via consensus diagnostic confer-
ence procedures. Patients were followed prospectively,
eliminating potential biases inherent in retrospective chart
reviews. Evaluations were performed annually, which pro-
vides multiple assessments of cost and permits more-accu-
rate coefficient estimates. The cohort had high rates of
follow-up participation with few missing data. Clinical
signs were ascertained and coded in a standardized fashion
at each visit. Finally, patients were recruited at early stages
of the disease and followed for long periods of time. The
cohort describes the full range of progression over time,
making longer-term effects on costs more easily interpreted.
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